We are live on ! Find out more
DCOY

Decoy Therapeutics
DCOY

3 hedge funds and large institutions have $2.01K invested in Decoy Therapeutics in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.02% less ownership

Funds ownership: 0.03% → 0.01% (-0.02%)

63% less funds holding

Funds holding: 8 → 3 (-5)

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

98% less capital invested

Capital invested by funds: $104K → $2.01K (-$102K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
-5
Holders Change %
-62.5%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ASN
Advisory Services Network
Georgia
+$3.87K
2
Osaic Holdings
Osaic Holdings
Arizona
+$461

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$28K
2
CSS
Cubist Systematic Strategies
Connecticut
-$15K
3
Goldman Sachs
Goldman Sachs
New York
-$14.9K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$13.9K
5
UBS Group
UBS Group
Switzerland
-$9.13K

DCOY Hedge Fund Activity: Q3 2025 in Review

3 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in Decoy Therapeutics (DCOY) for Q3 2025, worth a combined $2.01K — down 98% from $104K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of DCOY and 2 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Advisory Services Network, opening a new position worth an estimated $3.87K. The largest seller was HRT Financial, exiting entirely with an estimated $28K sold.

  • 3 institutional investors held Decoy Therapeutics (DCOY) as of Q3 2025, down from 8 in Q2 2025.
  • Funds reported $2.01K of Decoy Therapeutics stock for Q3 2025, down 98% quarter-over-quarter.
  • 2 funds opened new Decoy Therapeutics positions in Q3 2025 and 7 closed out, a net change of -5 holders.
  • The largest Decoy Therapeutics buyer in Q3 2025 was Advisory Services Network, an estimated $3.87K added.
  • The largest Decoy Therapeutics seller in Q3 2025 was HRT Financial, an estimated $28K sold.

Based on aggregated 13F filings for Q3 2025.